[HTML][HTML] Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials

CTR Vegivinti, KW Evanson, H Lyons, I Akosman… - BMC Infectious …, 2022 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …

Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials.

CTR Vegivinti, KW Evanson, H Lyons… - BMC Infectious …, 2022 - search.ebscohost.com
Abstract Background: Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …

[PDF][PDF] Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials

CTR Vegivinti, KW Evanson, H Lyons, I Akosman… - 2022 - researchgate.net
Abstract Background: Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …

[HTML][HTML] Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials

CTR Vegivinti, KW Evanson, H Lyons… - BMC Infectious …, 2022 - ncbi.nlm.nih.gov
Background Coronavirus disease 2019 (COVID-19) continues to pose a significant threat to
public health worldwide. The purpose of this study was to review current evidence obtained …

Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials

CTR Vegivinti, KW Evanson, H Lyons… - BMC Infectious …, 2022 - search.proquest.com
Background Coronavirus disease 2019 (COVID-19) continues to pose a significant threat to
public health worldwide. The purpose of this study was to review current evidence obtained …

Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials.

CTR Vegivinti, KW Evanson, H Lyons… - BMC Infectious …, 2022 - europepmc.org
Background Coronavirus disease 2019 (COVID-19) continues to pose a significant threat to
public health worldwide. The purpose of this study was to review current evidence obtained …

Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials.

CTR Vegivinti, KW Evanson, H Lyons, I Akosman… - 2022 - cabidigitallibrary.org
Abstract Background: Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …

Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials.

CTR Vegivinti, KW Evanson, H Lyons… - BMC Infectious …, 2022 - go.gale.com
Background Coronavirus disease 2019 (COVID-19) continues to pose a significant threat to
public health worldwide. The purpose of this study was to review current evidence obtained …

Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials

CTR Vegivinti, KW Evanson, H Lyons, I Akosman… - 2022 - ohioopen.library.ohio.edu
Background: Coronavirus disease 2019 (COVID-19) continues to pose a significant threat to
public health worldwide. The purpose of this study was to review current evidence obtained …

Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials

CTR Vegivinti, KW Evanson, H Lyons… - BMC infectious …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Coronavirus disease 2019 (COVID-19) continues to pose a significant threat to
public health worldwide. The purpose of this study was to review current evidence obtained …